Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2010-10-12 M&A Activity
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Vitrolife expands its IVF product portfolio through acquisition in the USA.
M&A Activity Classification · 98% confidence The document is explicitly titled 'Press Release' and announces a specific corporate action: the acquisition of Conception Technologies, USA. This type of announcement, detailing a merger or takeover proposal, directly aligns with the definition of M&A Activity (TAR). It is not a full annual report (10-K), an interim report (IR), or a general earnings release (ER). Since it is a specific announcement about a transaction, TAR is the most appropriate classification over the general Regulatory Filing (RNS). The length is sufficient to contain the details, so the RPA/RNS 'Menu vs Meal' rule does not apply to classify it as an announcement of a report.
2010-10-12 English
Vitrolife utökar IVF produktportföljen genom förvärv i USA.
M&A Activity Classification · 99% confidence The document is explicitly titled 'Pressmeddelande' (Press Release) and announces a significant corporate action: the acquisition of Conception Technologies in the USA. This type of announcement, detailing a merger or acquisition activity, directly corresponds to the 'M&A Activity' category. Although it is a formal announcement, the content is the substance of the M&A event itself, not merely an announcement that a report is forthcoming (which would suggest RPA or RNS). Therefore, TAR (M&A Activity) is the most appropriate classification.
2010-10-12 Swedish
Vitrolife launch a new generation of Growth Factors and Cytokines for cultivation of stem cells
Regulatory Filings Classification · 95% confidence The document is a 'Press Release' dated October 1, 2010, announcing the launch of new products (Growth Factors and Cytokines) and a Distribution and Supply Agreement. This type of announcement, which details a significant business development (product launch, partnership) but is not a formal regulatory filing like a 10-K, ER, or IR, typically falls under general corporate news. Since there is no specific category for 'Press Release' or 'Business Update,' and it does not fit the definitions for AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS, the most appropriate fallback category is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory announcements that don't fit elsewhere, often encompassing press releases that convey material information.
2010-10-01 English
Vitrolife lanserar en ny generation Tillväxtfaktorer och Cytokiner för stamcellsodling
Regulatory Filings Classification · 95% confidence The document is titled "Pressmeddelande" (Press Release) and announces a new product launch and a distribution agreement. It is short (3528 characters) and contains general company information at the end. This format strongly suggests a general corporate announcement rather than a detailed regulatory filing (like 10-K, IR, or ER) or a specific report type (like AR or DEF 14A). Since it is a general announcement that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Dividend (DIV), the most appropriate fallback category is Regulatory Filings (RNS), which often encompasses press releases that serve as official public disclosures when a more specific code isn't applicable. It is not an announcement *about* a report, but a report of business news.
2010-10-01 Swedish
Election committee for Vitrolife AB (publ)
AGM Information Classification · 95% confidence The document is a press release dated September 30, 2010, announcing the appointment of members to the election committee for the upcoming Annual General Meeting (AGM) in 2011. It also mentions the date of the AGM and procedures for submitting items for consideration. This content directly relates to the governance and preparation for the Annual General Meeting. While it is an announcement, it is not a general regulatory filing (RNS) or a report publication announcement (RPA) about a financial report. It specifically deals with the administrative setup for the AGM. The closest fit among the provided definitions is 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM. Since this document sets up the committee responsible for nominations for the AGM, it falls under the scope of AGM-related information.
2010-09-30 English
Valberedning i Vitrolife AB (publ)
Regulatory Filings Classification · 95% confidence The document is a press release dated September 30, 2010, announcing the composition of the Nomination Committee (Valberedning) for the upcoming 2011 Annual General Meeting (Årsstämma). It also mentions the date of the AGM (April 27, 2011) and provides instructions for shareholder proposals. This content relates directly to the governance and preparation for the Annual General Meeting. While it is a press release, its specific subject matter—the nomination committee and AGM logistics—aligns most closely with preparatory materials for the AGM. Since there is no specific code for 'Nomination Committee Announcement,' and the content is directly tied to the AGM process, AGM-R (AGM Information) is the most appropriate classification, as these materials are typically shared in connection with the AGM. It is not a DEF 14A (Remuneration) or a DVA (Voting Results). Given the context of setting up the committee for the AGM, AGM-R is selected.
2010-09-30 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.